A new treatment study has just begun at the Gottfries Clinic in Sweden. Professor Gottfries and his colleagues are collaborating with Nobel laureate Arvid Carlsson in this study, which will examine possible effects of the substance OSU 6162 on the brain exhaustion/mental fatigue ME patients experience. The study will be double-blind and placebo controlled. Both Fukuda and ICC will be used, and patients evaluated by experienced physicians at the Gottfries Clinic.
OSU 6162 has previously shown effects of mental fatigue in stroke patients
http://www1.cinp-congress.org/guest/IDa5f5d874720e5c/AbstractView?ABSID=9623
Prof Gottfries stresses that this substance wont cure ME/CFS, but might ease one of the symptoms.
Any thoughts on this? If I understand this correctly, OSU 6162 is a dopamine regulator. Does that mean it will increase levels of dopamine in the brain?
OSU 6162 has previously shown effects of mental fatigue in stroke patients
http://www1.cinp-congress.org/guest/IDa5f5d874720e5c/AbstractView?ABSID=9623
Prof Gottfries stresses that this substance wont cure ME/CFS, but might ease one of the symptoms.
Any thoughts on this? If I understand this correctly, OSU 6162 is a dopamine regulator. Does that mean it will increase levels of dopamine in the brain?